Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

N2-Deacetyl-N2-[4-methyl-4-(oxobutyldithio)-1-oxopentyl]-maytansine-chimerised anti-CD138 IgG4 Monoclonal Antibody

EU orphan designation number: EU/3/08/593   
Active ingredient: N2-Deacetyl-N2-[4-methyl-4-(oxobutyldithio)-1-oxopentyl]-maytansine-chimerised anti-CD138 IgG4 Monoclonal Antibody
Indication: Treatment of multiple myeloma
Sponsor: Biotest AG
Landsteinerstrasse 5, D-63303 Dreieich, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
05/12/2008 Centralised Orphan - Designation EMEA/OD/068/08 (2008)8096 of 03/12/2008